Qiuhua Li
Shenyang Pharmaceutical University(CN)Guizhou Normal University(CN)Guangdong Pharmaceutical University(CN)Shantou University(CN)Humboldt-Universität zu Berlin(DE)Guangdong Academy of Agricultural Sciences(CN)Tea Research Institute(CN)Ministry of Agriculture and Rural Affairs(CN)Czech Academy of Sciences, Institute of Physiology(CZ)The University of Texas Medical Branch at Galveston(US)Fujian Agriculture and Forestry University(CN)Charité - Universitätsmedizin Berlin(DE)Charité - Universitätsmedizin Berlin(DE)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Aquaculture disease management and microbiota, Tea Polyphenols and Effects, Epigenetics and DNA Methylation, Lung Cancer Treatments and Mutations, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)(2011)909 cited
- → An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms(2007)749 cited
- → Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma(2007)643 cited
- → PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models(2015)458 cited
- → Genome Sequencing of the Perciform Fish Larimichthys crocea Provides Insights into Molecular and Genetic Mechanisms of Stress Adaptation(2015)307 cited
- →